One included study (Laskaris et al., 2018) compared C1q, C3 and C4 levels in healthy controls with three groups of cases: patients with chronic schizophrenia, patients with FEP and individuals at clinical high-risk (CHR) for psychosis (Yung et al., 2005). The gene discussed is C3; the disease is psychotic disorder.